Characteristics of Osimertinib Non-Responders vs Responders in EGFR Mutated Lung Cancer

被引:0
|
作者
Reyes, A. [1 ]
Sampath, S. [1 ]
Muddasani, R. [1 ]
Afkhami, M. [1 ]
Amini, A. [1 ]
Villaflor, V. [1 ]
Salgia, R. [1 ]
Rock, A. [1 ]
Li, X. [1 ]
Massarelli, E. [1 ]
机构
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
关键词
EGFRMutated; Osimertinib; Response;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP.12A.29
引用
收藏
页码:S632 / S632
页数:1
相关论文
共 50 条
  • [41] Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
    Ashina, Sait
    Melo-Carrillo, Agustin
    Toluwanimi, Ajayi
    Bolo, Nicolas
    Szabo, Edina
    Borsook, David
    Burstein, Rami
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [42] Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
    Sait Ashina
    Agustin Melo-Carrillo
    Ajayi Toluwanimi
    Nicolas Bolo
    Edina Szabo
    David Borsook
    Rami Burstein
    The Journal of Headache and Pain, 24
  • [43] BASELINE CHARACTERISTICS OF PATIENTS WITH MODERATE TO SEVERE PSORIATIC ARTHRITIS: POST-HOC ANALYSIS OF RESPONDERS VS NON-RESPONDERS TO ETANERCEPT
    Gisondi, P.
    Girolomoni, G.
    de Vlam, K.
    Al Hammadi, A.
    Carneiro, S.
    Hsu, M. -A.
    Szumski, A.
    Jones, H.
    Gallo, G.
    Chhabra, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1174 - 1174
  • [44] Options for non-responders to monotherapy
    Bacon, B
    NON-RESPONDING HEPATITIS C PATIENT: OPTIONS AND VARIABLES, 2000, (70): : 5 - 13
  • [45] Characteristics of non-responders to diabetes service use questionnaires
    Goyder, EC
    Botha, JL
    PUBLIC HEALTH, 2001, 115 (01) : 78 - 79
  • [46] What to do with non-responders
    Villanueva, C
    Aracil, Q
    Balanzó, J
    PORTAL HYPERTENSION IN THE 21ST CENTURY, 2004, : 337 - 348
  • [47] Differences between responders and non-responders of bilateral thoracoscopic lung volume reduction surgery (LVRS)
    Hamacher, J
    Stammberger, U
    Bloch, KE
    Ritscher, D
    Weder, W
    Russi, EW
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A925 - A925
  • [48] Distinct Clinical Outcomes of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor (EGFR) Mutations Treated with EGFR Tyrosine Kinase Inhibitors: Non-Responders versus Responders
    Hsiao, Shih-Hsin
    Liu, H. Eugene
    Lee, Hsin-Lun
    Lin, Chii-Lan
    Chen, Wei-Yu
    Wu, Zhung-Han
    Lin, Sey-En
    Chiang, Ling-Ling
    Chung, Chi-Li
    PLOS ONE, 2013, 8 (12):
  • [49] Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique
    Majd, Elham
    Xing, Li
    Zhang, Xuekui
    BMC MEDICAL RESEARCH METHODOLOGY, 2024, 24 (01)
  • [50] Responders And Non-responders To Hiit In Cancer Survivors; Implications For Body Composition And Systemic Inflammation?
    Boytar, Alex N.
    Farley, Morgan J.
    Salisbury, Chloe E.
    Skinner, Tina L.
    Jenkins, David G.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 1091 - 1091